A cDNA for a rat vesicular monoamine transporter, desgatd MAT, was isolated by expression cloning in a mammalian cell line (CV-1). (1-4) . The biogenic amine Na+-dependent transporters (reuptake transporters) located at the plasma membrane are responsible for transport of the released monoamines back into the cytoplasm, where they may be repackaged by the vesicular transporter into storage organelles or degraded by monoamine oxidases (5, 6).
ATPase. The rank order of potency to inhibit uptake was reserpine > tetrahenazine > serotonin > dpine> norepinephrine > epinephrine. Direct comparison of [3Htmonoamine uptake indicated that serotonin was the preferred subsrae. Photolabeling of membranes prepared from CV-1 ces express ing MAT with 7-azido-84 ['51idoketanserin revealed a predominant tetrabenazine-sensitive photolabeled glycoprotein with an apparent molecular mass of -75 kDa. The mRNA that encodes MAT was present specifically in monoamine-containing cells of the locus coeruleus, substantia nigra, and raphe nucleus ofrat brain, each ofwhich expresses a unique plasma membrane reuptake transporter. The MAT cDNA clone defines a vesicular monoamine transporter representing a distinct class of neuroIransmitter transport molecules. Vesicular monoamine transporters (MATs) facilitate the ATP-dependent accumulation of biogenic amine neurotransmitters into secretory organelles of neurons, enterochromaffin cells, platelets, and mast cells. Monoamine transport occurs in exchange for intravesicular protons (substrate/H+ antiporter) and is requisite for vesicular amine storage prior to secretion via exocytosis (1) (2) (3) (4) . The biogenic amine Na+-dependent transporters (reuptake transporters) located at the plasma membrane are responsible for transport of the released monoamines back into the cytoplasm, where they may be repackaged by the vesicular transporter into storage organelles or degraded by monoamine oxidases (5, 6) .
Several distinguishing features of the MAT are as follows: (i) broad selectivity for 5-hydroxytryptamine (serotonin) (5HT), dopamine (DA) , and norepinephrine (NE) uptake, (ii) specific inhibition of transport by reserpine (RES) and tetrabenazine (TBZ), and (iii) transmembrane H+-electrochemical dependence of monoamine accumulation (1) (2) (3) (4) . Furthermore, photoaffinity labeling of storage vesicles from brain, adrenal medulla, and platelets from different species with 7-azido-8-[1251] (7) (8) (9) .
It has been proposed that the type of neurotransmitter found in monoaminergic cells is governed by expression of the specific biosynthetic enzymes and the appropriate and specific plasma membrane reuptake transporter, with a vesicular transporter of relatively broad selectivity (10, 11) . Recently, several biogenic amine reuptake transporters have been cloned (12) (13) (14) (15) (16) (17) 47 [3HJ5HT Accumulation in Intact CV-1 Cells. The uptake studies were conducted as described (13, 17) with the uptake buffer at pH 6.8, 7.4, and 8.0. [3H]Monoamine Uptake in Permeabilized CV-1 Cells. tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. L00603).
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. vesicle membrane has been tentatively assigned (Fig. 1B) based on the lack of apparent signal sequence with five potential N-linked glycosylation sites facing the vesicle lumen, and NH2 and COOH tails in the cytoplasm.
Of the 72 charged (35 negative residues and 37 positive residues) amino acids, 11 are potentially located in the transmembrane domains. The slow, pH-sensitive, and low-affinity accumulation of monoamines in intact CV-1 cells expressing MAT suggested that the amines cross the plasma membrane by passive diffusion of the neutral species. Once inside the cell, the monoamines become protonated and available to MAT located on an intracellular compartment. Thus, the affinity constants for intact cells are only apparent, related to the true values for uptake at an intracellular compartment by true Km apparent Km x 10-PK/(H+). The true Km value for
[3H]5HT is -1.8 ,uM if passive diffusion of the neutral amine (pKa 9.8) across the plasma membrane (pH 7.4) must occur first.
[3H]Monoamine Uptake in Digitonin-Permeabilized CV-1 Cells Expressing MAT cDNA. To access intracellular compartments, the plasma membrane was selectively permeabilized with digitonin (25, 26) . Permeabilization of CV-1 cells with digitonin in intracellular medium eliminates the normal ionic gradients across the plasma membrane and abolished Na+-dependent 5HTT function. In permeabilized cells expressing MAT, [3H15HT uptake was inhibited by 100 nM RES to levels in mock-transfected CV-1 cells (Fig. 2A) . RESsensitive [3H]5HT uptake was reduced by >80o in the absence of ATP. In addition, [3H]SHT uptake was abolished by the proton translocating ionophore carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) (5 ,uM) or by inhibition of the vacuolar H+-ATPase with tri-(n-butyl)tin (TBT) (50 ,uM) . Uptake was saturable with an apparent Km of 1.3 ,uM (Fig. 2B) . The biogenic amines (10 ,uM) bovine chromaffin granules (=70 kDa) and RBL cells (75 kDa). In cells expressing the MAT cDNA, a membrane protein of =75 kDa displayed TBZ-sensitive photolabeling but was absent from 5HTT-expressing CV-1 cells. A smaller (=50 kDa) photolabeled protein seen only in MAT transfected CV-1 cells also displayed TBZ sensitivity and may be a MAT proteolytic cleavage product. Both the =50-kDa membrane component and the larger =75-kDa photolabeled protein are glycosylated, since treatment of membranes from CV-1 cells expressing MAT with N-glycopeptidase caused both photolabeled polypeptides to be reduced in size by =20 kDa. As all potential N-glycosylation sites are in the first intraluminal loop (Fig. 1) , the photolabeled site may be located within the first eight transmembrane domains of MAT. The additional photolabeled membrane protein of =90 kDa observed in CV-1 cells was not displaceable by TBZ, ketanserin, mianserin, chlorpheniramine, or prazosin at 2 ,uM and probably represents nonspecific photolabeling.
Distribution of MAT mRNA in Rat Brain and Peripheral Tissues. MAT cDNA hybridized to mRNAs of three different sizes (Fig. 4) . observed in RBL 2H3 (-2.2 kb) and in the brainstem (-2.9 and -2.2 kb) may result from the use of different polyadenylylation sites (Fig. 1) . Hybridization was not observed in kidney, liver, lung, heart, or testis, or in the cerebellum, hippocampus, and cerebral cortex of the brain. ISHH clearly showed labeling for MAT in brainstem nuclei (Fig. 5) . Adjacent sections were identified with probes specific for 5HTT, DAT, and NET. MAT mRNA was not detected in adrenal gland by ISHH.
DISCUSSION
A cDNA clone for a rat MAT was isolated from a rat basophilic leukemia cell line (RBL 2H3) cDNA library. This rat cDNA (2.9 kb) represents a distinct class of neurotransmitter transporter molecules with 12 putative transmembrane domains having no significant homology to other known proteins, including the rat biogenic amine reuptake transporters and the human Na+/H+ antiporter. There is limited homology in the transmembrane domains of the metaltetracycline/H+ antiporter of Escherichia coli (27). The charged and polar amino acid residues in the transmembrane domains of MAT may play a critical role in the mechanism of monoamine/H+ antiport as shown by mutagenesis studies for .3 ,uM) is similar to the Km for monoamine uptake in synaptic vesicles from rat brain (38-41) and RBL 2H3 cells (42). The broad specificity of transport by MAT in permeabilized CV-1 cells is also a distinguishing feature of the MAT (11, 43, 44) .
The cDNA screening strategy for MAT relied on two processes of [3H]5HT uptake in intact cells: diffusion of the neutral amine across the plasma membrane followed by uptake into an intracellular compartment. The rank order of potency for inhibition of [3H]5HT accumulation into intact CV-1 cells expressing MAT by the biogenic amines was nevertheless identical to that in permeabilized cells. Furthermore, the potency of RES to inhibit [3H]5HT uptake (12.5 nM) in intact cells was comparable to Ki values (=10 nM) obtained with in vitro preparations of monoaminergic storage organelles (3, 45, 46 
